TVPW
EW icon

Third View Private Wealth’s Edwards Lifesciences EW Stock Holding History

Third View Private Wealth’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$709K Buy
7,834
+3,147
+67% +$264K 0.09% 154
2026
Q1 		$375K Buy
4,687
+5
+0.1% +$412 0.05% 200
2025
Q4 		$399K Buy
+4,682
New +$384K 0.05% 193

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
WT
Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
Universal-Beteiligungs- und Servicegesellschaft
Universal-Beteiligungs- und Servicegesellschaft Frankfurt Am Main, Germany $65.4B AUM 39.83% 1-Year Est. Return

Third View Private Wealth's EW Position: Q2 2026 in Review

Third View Private Wealth increased its Edwards Lifesciences (EW) stake by 67% in Q2 2026, buying an estimated $264K and bringing the position to 7,834 shares worth $709K. The position accounts for 0.09% of the portfolio, ranked #154.

Third View Private Wealth first reported a position in EW in Q4 2025 and has held it in 3 quarters since. 774 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Third View Private Wealth held 7,834 shares of Edwards Lifesciences worth $709K as of Q2 2026.
  • Third View Private Wealth bought 3,147 Edwards Lifesciences shares in Q2 2026, an estimated $264K.
  • Edwards Lifesciences made up 0.09% of Third View Private Wealth's portfolio in Q2 2026, its #154 holding.
  • Third View Private Wealth first reported a position in Edwards Lifesciences in Q4 2025 and has held it in 3 quarters since.
  • 774 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Third View Private Wealth's 13F filing for Q2 2026, filed 27 Jul 2026.